Evidence map›Paper›PMID 22387014›Full record

ArticleAmerican journal of human genetics2012

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

Lora Boteva, David L Morris, Josefina Cortés-Hernández, Javier Martin, Timothy J Vyse, Michelle M A Fernando

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Exosomal-complement system activation in preeclampsia.The journal of obstetrics and gynaecology research · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Genetics in Behcet's Disease: An Update Review.Frontiers in ophthalmology · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lora BotevaDivision of Genetics and Molecular Medicine, Guy's Hospital, King's College London, UK.
David L Morris
Josefina Cortés-Hernández
Javier Martin
Timothy J Vyse
Michelle M A Fernando
Guy's Hospital · GBConsejo Superior de Investigaciones Científicas · ESKing's College London · GB

Funding

Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KLARESKOG, LARS · 2005 to 2009
$10.1M
Arthritis Research UK 18239Medical Research Council G0000934NIAID NIH HHS AI067152NIAID NIH HHS U19 AI067152Wellcome TrustWellcome Trust 068545/Z/02
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease. Complete deficiency of complement component C4 confers strong genetic risk for SLE. Partial C4 deficiency states have also shown association with SLE, but despite much effort over the last 30 years, it has not been established whether this association is primarily causal or secondary to long-range linkage disequilibrium. The complement C4 locus, located in the major histocompatibility complex (MHC) class III region, exhibits copy-number variation (CNV) and C4 itself exists as two paralogs, C4A and C4B. In order to determine whether partial C4 deficiency is an independent genetic risk factor for SLE, we investigated C4 CNV in the context of HLA-DRB1 and MHC region SNP polymorphism in the largest and most comprehensive complement C4 study to date. Specifically, we genotyped 2,207 subjects of northern and southern European ancestry (1,028 SLE cases and 1,179 controls) for total C4, C4A, and C4B gene copy numbers, and the loss-of-function C4 exon 29 CT indel. We used multiple logistic regression to determine the independence of C4 CNV from known SNP and HLA-DRB1 associations. We clearly demonstrate that genetically determined partial C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. These results are further corroborated by the lack of association shown by the C4A exon 29 CT insertion in either cohort. Thus, although complete homozygous deficiency of complement C4 is one of the strongest genetic risk factors for SLE, partial C4 deficiency states do not independently predispose to the disease.

Indexed as

DNA Copy Number VariationsAllelesCase-Control StudiesCohort StudiesComplement C4aComplement C4bExonsGene DosageGene FrequencyGenetic Predisposition to DiseaseHaplotypesHLA-DRB1 ChainsHomozygoteHumansLinkage DisequilibriumLogistic ModelsComplement C4aComplement C4bHLA-DRB1 Chains

Identifiers

PMID22387014
PMCPMC3309188
OpenAlexW2083515064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.